Citadel Advisors
STRM

Citadel Advisors’s Streamline Health Solutions STRM Stock Holding History

Citadel Advisors’s Portfolio STRM Stock Details STRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7,862
Closed -$114K – 15216
2023
Q3 		$114K Buy
7,862
+4,420
+128% +$76.7K ﹤0.01% 10717
2023
Q2 		$65.6K Sell
3,442
-58
-2% -$1.4K ﹤0.01% 11482
2023
Q1 		$94.5K Buy
3,500
+1,327
+61% +$37.7K ﹤0.01% 11348
2022
Q4 		$51.5K Buy
2,173
+1,175
+118% +$28.6K ﹤0.01% 12097
2022
Q3 		$18K Buy
+998
New +$22.4K ﹤0.01% 12114
2022
Q2 		– Sell
-701
Closed -$17K – 14065
2022
Q1 		$17K Buy
+701
New +$15K ﹤0.01% 13287
2018
Q4 		– Sell
-1,063
Closed -$19K – 9733
2018
Q3 		$19K Buy
+1,063
New +$20.3K ﹤0.01% 9018
2017
Q2 		– Sell
-1,495
Closed -$23K – 8037
2017
Q1 		$23K Buy
+1,495
New +$28K ﹤0.01% 7217
2016
Q2 		– Sell
-817
Closed -$17K – 7376
2016
Q1 		$17K Buy
+817
New +$18.4K ﹤0.01% 6515

Other funds holding STRM

TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AWM
Austin Wealth Management Austin, Texas $440M AUM 17.66% 1-Year Est. Return
HIM
Herald Investment Management London, United Kingdom $718M AUM 91.16% 1-Year Est. Return
NHC
Nicholas Hoffman & Company Atlanta, Georgia $4.33B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors's STRM Position: Q4 2023 in Review

Citadel Advisors sold out of Streamline Health Solutions (STRM) in Q4 2023, closing a stake of 7,862 shares — an estimated $114K sold.

Citadel Advisors first reported a position in STRM in Q1 2016 and held it in 9 quarters. The position peaked at $114K in Q3 2023. 40 funds tracked by Wall St. Rank hold STRM as of Q4 2023.

  • Citadel Advisors reported no remaining Streamline Health Solutions position as of Q4 2023 after selling out during the quarter.
  • Citadel Advisors sold 7,862 Streamline Health Solutions shares in Q4 2023, an estimated $114K.
  • Citadel Advisors first reported a position in Streamline Health Solutions in Q1 2016 and held it in 9 quarters.
  • Citadel Advisors's Streamline Health Solutions position peaked at $114K in Q3 2023.
  • 40 funds tracked by Wall St. Rank held Streamline Health Solutions as of Q4 2023.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.